News
The stock's fall snapped a four-day winning streak.
1d
Zacks.com on MSNMRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 ShotsThough the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer ...
We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...
Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.
Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...
Consolidation is likely to continue, with the indices attempting to defend the previous Thursday’s low in the upcoming ...
Pfizer share price gained 13% in the intraday trades on Tuesday post Q4 Results, dividend announcement and despite stock ...
Pfizer also announced a hefty total dividend of Rs 165 per equity share for FY25. This includes a final dividend of Rs 35 per ...
Shares of Pfizer Inc. PFE advanced 1.02% to $22.83 Friday, on what proved to be an all-around favorable trading session for ...
If you see a stock that pays 6% in dividends, you might assume it's too risky -- but that's not always the case. In some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results